Literature DB >> 32058869

Mesoporous polydopamine with built-in plasmonic core: Traceable and NIR triggered delivery of functional proteins.

Di Wu1, Jiajing Zhou2, Xiaohong Chen3, Yonghao Chen2, Shuai Hou2, Hehe Qian4, Lifeng Zhang4, Guping Tang4, Zhong Chen5, Yuan Ping6, Wenjun Fang7, Hongwei Duan8.   

Abstract

Functional proteins are essential for the regulation of cellular behaviors and have found growing therapeutic uses. However, low bioavailability of active proteins to their intracellular targets has been a long-standing challenge to achieve their full potential for cell reprogramming and disease treatment. Here we report mesoporous polydopamine (mPDA) with a built-in plasmonic nanoparticle core as a multifunctional protein delivery system. The mPDA with a unique combination of large surface area, metal-chelating property, and broad-spectrum photothermal transduction allows efficient loading and near-infrared light-triggered release of functional proteins, while the plasmonic core serves as a photostable tracer and fluorescence quencher, collectively leading to real-time monitoring and active cytosolic release of model proteins. In particular, controlled delivery of cytotoxic ribonuclease A has shown excellent performance in invivo cancer therapy. The possibility of coating mPDA on a broad range of functional cores, thanks to its universal adhesion, provides opportunities for developing tailored delivery carriers of biologics to overcome intrinsic biological barriers.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer therapy; Mesoporous polydopamine; Photothermal-responsive; Plasmonic nanostructures; Traceable protein delivery

Mesh:

Substances:

Year:  2020        PMID: 32058869     DOI: 10.1016/j.biomaterials.2020.119847

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Construction of Double-Shelled Hollow Ag2S@Polydopamine Nanocomposites for Fluorescence-Guided, Dual Stimuli-Responsive Drug Delivery and Photothermal Therapy.

Authors:  Minjie Gao; Zehua Han; Xu Zhang; Xueyan Zou; Lichao Peng; Yanbao Zhao; Lei Sun
Journal:  Nanomaterials (Basel)       Date:  2022-06-15       Impact factor: 5.719

Review 2.  Single and Multiple Stimuli-Responsive Polymer Particles for Controlled Drug Delivery.

Authors:  Aida López Ruiz; Ann Ramirez; Kathleen McEnnis
Journal:  Pharmaceutics       Date:  2022-02-15       Impact factor: 6.321

3.  Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy.

Authors:  Xiaoxue Xie; Yi Feng; Hanxi Zhang; Qingqing Su; Ting Song; Geng Yang; Ningxi Li; Xiaodan Wei; Tingting Li; Xiang Qin; Shun Li; Chunhui Wu; Xiaojuan Zhang; Guixue Wang; Yiyao Liu; Hong Yang
Journal:  Bioact Mater       Date:  2022-03-11

Review 4.  Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics.

Authors:  Menglu Zhu; Yi Shi; Yifan Shan; Junyan Guo; Xuelong Song; Yuhua Wu; Miaolian Wu; Yan Lu; Wei Chen; Xiaoling Xu; Longguang Tang
Journal:  J Nanobiotechnology       Date:  2021-11-24       Impact factor: 10.435

5.  Photothermal-Controlled Release of IL-4 in IL-4/PDA-Immobilized Black Titanium Dioxide (TiO2) Nanotubes Surface to Enhance Osseointegration: An In Vivo Study.

Authors:  Bo Chen; Yu Liang; Yunjia Song; Yunkai Liang; Jian Jiao; Hong Bai; Ying Li
Journal:  Materials (Basel)       Date:  2022-08-29       Impact factor: 3.748

6.  Robust and Versatile Coatings Engineered via Simultaneous Covalent and Noncovalent Interactions.

Authors:  Jiajing Zhou; Matthew Penna; Zhixing Lin; Yiyuan Han; René P M Lafleur; Yijiao Qu; Joseph J Richardson; Irene Yarovsky; Jesse V Jokerst; Frank Caruso
Journal:  Angew Chem Int Ed Engl       Date:  2021-08-06       Impact factor: 16.823

Review 7.  Polydopamine-based nanoreactors: synthesis and applications in bioscience and energy materials.

Authors:  Shilin Mei; Xiaohui Xu; Rodney D Priestley; Yan Lu
Journal:  Chem Sci       Date:  2020-10-21       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.